Avesta Pharma Private Limited - Company Profile

It is a manufacturing private limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Avesta Pharma Private Limited

Avesta Pharma Private Limited, a active private limited company, was established on 25 May 2009 in Mumbai, Maharashtra, India. Engaging in plastic & resins within the manufacturing sector, it holds CIN: U24239MH2009PTC192677. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a compliant status. Employing 124 professional, Its leadership includes Eric Kersi Tangri (Director), Zubin Keki Gandhi (Director), Amol Ashok Walke (Director). Past directors included Eric Kersi Tangri, Sonal Kersi Tangri, Amol Ashok Walke. It holds ₹55.90 Cr open charges and ₹25.91 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 106 / 108 , Shivam Chambers, 1St Floor S.V.Road, Goregaon West, Mumbai, Maharashtra, 400062.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2009PTC192677

  • Registration Number

    192677

  • Incorporation Date

    25 May 2009

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 16 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 55.90 Cr
  • Satisfied Charges ₹ 25.91 Cr
  • Revenue Growth **** 52.19%
  • Profit Growth **** 139.25%
  • Ebitda **** 122.53%
  • Net Worth 224.31%
  • Total Assets **** 57.46%
Company report

Avesta Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avesta Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avesta Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Eric Kersi Tangri Director 01 Mar 2024 Current
Zubin Keki Gandhi Director 30 Nov 2009 Current
Amol Ashok Walke Director 01 Apr 2015 Current
Mahesh Hakmichand Doshi Director 01 Apr 2015 Current
Kersi Homi Tangri Director 25 May 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 03 Feb 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avesta Pharma.

Avesta Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.19% increase. The company also saw a substantial improvement in profitability, with a 139.25% increase in profit. The company's net worth Soared by an impressive increase of 224.31%.

Avesta Pharma revenue growth over time
Avesta Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 52.19%
*******
*******
*******
*******
Revenue from Operations
*******
 55.28%
*******
*******
*******
*******
Total Assets
*******
 57.46%
*******
*******
*******
*******
Profit or Loss
*******
 139.25%
*******
*******
*******
*******
Net Worth
*******
 224.31%
*******
*******
*******
*******
EBITDA
*******
 122.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avesta Pharma?

In 2023, Avesta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹558,950,000.00

Satisfied Charges

₹259,075,000.00

Charges Breakdown by Lending Institutions
  • Others : 55.90 Cr
Latest Charge Details
Date Lender Amount Status
03 Aug 2021 Others ₹55.90 Cr Open
18 Aug 2011 Bank Of India ₹18.00 Cr Satisfied
18 Aug 2011 Bank Of India ₹7.91 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Avesta Pharma?

Avesta Pharma has a workforce of 124 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avesta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesta Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avesta Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Avesta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Avesta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Eric Kersi Tangri was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 55.90 Cr registered on 03 Aug 2021 with Charge ID 100480251 was modified on 15 Mar 2023. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 55.90 Cr with Charge ID 100480251 was registered on 03 Aug 2021. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 18 Aug 2011 via Charge ID 10310347 with Bank Of India was fully satisfied on 12 Jul 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avesta Pharma Private Limited?

The CIN of Avesta Pharma Private Limited is U24239MH2009PTC192677.

Where is Avesta Pharma Private Limited headquartered?

Avesta Pharma Private Limited is headquartered at 106 / 108 , Shivam Chambers, 1St Floor S.V.Road, Goregaon West, Mumbai, Maharashtra, 400062.

When was Avesta Pharma Private Limited incorporated?

Avesta Pharma Private Limited was incorporated on 25 May 2009.

Who are the current directors of Avesta Pharma Private Limited?

The current directors of Avesta Pharma Private Limited are

What is the primary industry of Avesta Pharma Private Limited?

The primary industry of Avesta Pharma Private Limited is Manufacturing.

Is Avesta Pharma Private Limited a listed company?

Avesta Pharma Private Limited is unlisted.

What is the capital structure of Avesta Pharma Private Limited?

The authorized capital of Avesta Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Avesta Pharma Private Limited?

The compliance status of Avesta Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available